June 6 (UPI) -- Opioid manufacturer Insys Therapeutics agreed to pay $225 million to settle the government's criminal and civil investigations into the company's unlawful bribery scheme.
As part of the global resolution, Insys will plead guilty to five counts of mail fraud as well as pay $195 million to settle allegations that it violated the False Claims Act, a $28 million forfeiture and a $2 million criminal fine, the U.S. Department of Justice announced on Wednesday.